AstraZeneca vaccine approval to give Canada ‘greater flexibility’ in distributing doses widely, says health official

Procurement Minister Anita Anand suggests the latest approval marks a vindication of the 'diversification' strategy the government settled on as it moved to negotiate deals with seven 'leading' vaccine manufacturers.

Dr. Supriya Sharma, chief medical adviser with Health Canada, pictured in December 2020, cautions against placing too much emphasis on the efficacy rate of the AstraZeneca vaccine. She says a key metric of a vaccine's benefits is whether it reduces or eliminates the likelihood of hospitalization and death due to the virus. The Hill Times photograph by Andrew Meade

News

BY BEATRICE PAEZ

February 26, 2021

Health Canada’s approval of the AstraZeneca COVID-19 vaccine on Friday will give Canada “greater flexibility” in distributing supplies more widely across the country once it starts to receive the more than 20 million doses on order, say federal officials....

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.

Already a Subscriber?

Get Today’s Headlines Newsletter

Your quick scan of the news you need each weekday to be the smartest person in the room.

By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy